P/E Ratio
Higher than 74% of Technology sector peers
Updated 70h ago
Sector Performance
74th percentileMRVL
60.4x
Sector Median
37.0x
Sector Avg
113.0x
Deep Analysis
The P/E ratio of 60.4x means investors are paying $60.40 for every $1 of Marvell's trailing earnings, indicating a high expectation of future profit growth.
That ratio towers above the Technology sector median of 37.0x, placing Marvell in the 74th percentile among its peers. Over the last eight quarters the trend direction has been increasing, but the year-over-year change is not available; quarter-over-quarter the ratio fell 0.7% from 60.8x to 60.4x. A high P/E combined with a long-term rising trend suggests the stock carries elevated growth expectations, which can create risk if those expectations are not met, but also opportunity if earnings accelerate. This metric contradicts the overall BULLISH verdict because the premium valuation already prices in substantial optimism, leaving little margin for error.
Frequently Asked Questions
What does the P/E Ratio tell investors about MRVL?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
How does MRVL's P/E Ratio compare to its sector?
MRVL's P/E Ratio of 60.4x compares to a Technology sector median of 37.0x, placing it in the 74th percentile.
Who are MRVL's closest peers by P/E Ratio?
The closest Technology peers by P/E Ratio include: LIF (20.9x), DELL (18.9x), UBER (18.2x), CRM (17.3x), WEX (16.3x).
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master MRVL's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MRVL research report →MRVL
60.4x
Sector Median
37.0x
Sector Avg
113.0x
How MRVL's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.